Ventrus Biosciences (NASDAQ:VTUS)

CAPS Rating 2 out of 5 
VTUS VS S&P 500 (SPY)

VTUS News and Commentary

Related News and Articles

How do you think VTUS will perform against the market?

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

17 Outperform
5 Underperform
 

All-Star Players

3 Outperform
3 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top VTUS Bull/Bear Pitches

zzlangerhans (99.67)
Submitted December 23, 2011

One of the funnier disagreements I had in 2011 was with ProActive Capital Resources, a PR firm hired by Ventrus. If I still have the top bear pitch you can read the exchange to your right. Why the company felt that I merited a response is beyond me.… More

Fools bullish on VTUS
are also bullish on:

zzlangerhans (99.67)
Submitted March 22, 2011

When I call Ventrus a niche pharma, I'm not kidding. All their products relate to anorectal health. I recently looked over their pipeline, and the word which came to my mind is "why?". The company makes a lot of hay about the lack of FDA approved… More

Featured Broker Partners


Advertisement